Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Burgos – page 4

88 clinical trials in Burgos, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Burgos at a glance
88
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

88 trials in Burgos

Open in trial search

Pre-eclampsia

Not yet recruiting

Acetylsalicylic Acid for Preventing Preeclampsia in Pregnant Women

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Craniocerebral injury

Not yet recruiting

A Study Testing Propranolol for Patients with Traumatic Brain Injury Who Need Intensive Care Unit Treatment

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Propranolol Hydrochloride
  • Sponsor:University Hospital Son Espases

Immune thrombocytopenia

Not yet recruiting

Study on the Safety and Effectiveness of Budoprutug in Patients with Immune Thrombocytopenia

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Budoprutug
  • Sponsor:Climb Bio Inc.

Acute leukaemia+2

Not yet recruiting

Study Comparing Fosfomycin and Ciprofloxacin for Preventing Fever in Patients with Acute Leukemia After Chemotherapy or Stem Cell Transplant

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ciprofloxacin
  • Sponsor:Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias

Anal fissure

Not yet recruiting

Study on Treating Chronic Anal Fissure in Patients Using Ultrasound-Guided Injections of Botulinum Toxin A

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Hospital Universitario de Burgos

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Acute myeloid leukaemia

Not yet recruiting

Study on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Servier Affaires Medicales
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
  • Sponsor:GlaxoSmithKline Biologicals

Breast cancer

Not recruiting

Study of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Camizestrant
  • Sponsor:AstraZeneca AB

Efficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cobolimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

A Study to Test How Safe Budoprutug Is and How Well It Works in Patients with Immune Thrombocytopenia

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Budoprutug
  • Sponsor:Climb Bio Inc.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Burgos

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials investigating treatments for various cancers, including hepatocellular carcinoma, breast cancer, and neuroendocrine tumors. Studies focus on evaluating novel therapeutic combinations and targeted treatments.

  • HER2-positive breast cancer therapies
  • Advanced liver cancer treatments
  • Colon cancer interventions

Several trials are exploring immunotherapy combinations and precision medicine approaches for better patient outcomes.

02 Hematological Disorders

Research focusing on blood disorders including immune thrombocytopenia, acute myeloid leukemia, and mantle cell lymphoma. Studies evaluate both novel therapies and treatment combinations.

  • ITP treatment innovations
  • Leukemia interventions
  • Lymphoma therapies

Trials aim to improve treatment responses and patient outcomes in various blood disorders.

03 Neurological Conditions

Clinical research examining treatments for Huntington's Disease and Parkinson's Disease, with a focus on cognitive improvements and disease modification strategies.

  • Cognitive function studies
  • Disease-modifying therapies
  • Long-term treatment effects

Investigations include both novel compounds and repurposed medications for neurodegenerative conditions.

04 Respiratory Medicine

Studies examining treatments for respiratory syncytial virus and chronic obstructive pulmonary disease, including vaccine development and therapeutic interventions.

  • RSV vaccine trials
  • COPD management
  • Pulmonary embolism treatment

Research focuses on both preventive strategies and treatment optimization.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.